, WHO. Obesity and overweight, 2018.
Global burden of obesity in 2005 and projections to 488 2030, Int J Obes (Lond), vol.32, pp.1431-1438, 2008. ,
Metabolic Syndrome and Menopause: Pathophysiology, 490 Clinical and Diagnostic Significance, Advances in clinical chemistry, vol.72, pp.1-75, 2015. ,
Endocrine disruptors: from endocrine to metabolic disruption ,
, Annual review of physiology, vol.73, pp.135-62, 2011.
Endocrine-disrupting chemicals 494 and the regulation of energy balance, Nature reviews Endocrinology, vol.13, pp.536-582, 2017. ,
Role of environmental chemicals in diabetes and 496 obesity: a National Toxicology Program workshop review. Environmental health perspectives, vol.497, pp.779-89, 2012. ,
Endocrine disrupting chemicals in ,
URL : https://hal.archives-ouvertes.fr/inserm-01848536
Menopausal Hormone Therapy and 586 Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications, Endocrine reviews, vol.587, pp.173-88, 2017. ,
Adipokine dysregulation, adipose tissue inflammation and metabolic 589 syndrome, Molecular and cellular endocrinology, vol.314, pp.1-16, 2010. ,
Determinants of body fat distribution in 591 humans may provide insight about obesity-related health risks, Journal of lipid research, 2018. ,
Metabolic impact of estrogen signalling through ERalpha and 593 ,
The Journal of steroid biochemistry and molecular biology, vol.122, pp.74-81, 2010. ,
GPR30 regulates diet-induced 595 adiposity in female mice and adipogenesis in vitro, Scientific reports, vol.6, p.34302, 2016. ,
The 597 androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia 598 in female mice. FASEB journal : official publication of the Federation of American Societies for 599 Experimental Biology, vol.29, pp.1540-50, 2015. ,
The sexually dimorphic role of 601 adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, 602 and fibrosis. Molecular metabolism, vol.2, pp.227-269, 2013. ,
Tetradian oscillation of estrogen 604 receptor alpha is necessary to prevent liver lipid deposition. Proceedings of the National Academy of 605 Sciences of the United States of America, vol.109, pp.11806-11817, 2012. ,
Nuclear receptors and 607 nonalcoholic fatty liver disease, Biochimica et biophysica acta, vol.1859, pp.1083-99, 2016. ,
Overexpression of estrogen receptor alpha increases hepatic 609 cholesterogenesis, leading to biliary hypersecretion in mice, Journal of lipid research, vol.47, pp.778-610, 2006. ,
Chronic exposure to a pollutant 612 mixture at low doses led to tissue-specific metabolic alterations in male mice fed standard and high-613 fat high-sucrose diet, Chemosphere, vol.220, pp.1187-99, 2019. ,
Lifelong consumption of low-dosed food 615 pollutants and metabolic health, Journal of epidemiology and community health, vol.69, pp.512-517, 2015. ,
Environmental Pollutants and Metabolic 617 Disorders: The Multi-Exposure Scenario of Life, Frontiers in endocrinology, vol.9, p.582, 2018. ,
EDC-2: The Endocrine 619 Society's Second Scientific Statement on Endocrine-Disrupting Chemicals, Endocrine reviews, vol.620, pp.1-150, 2015. ,
Endocrine disruptors in the etiology of type 2 diabetes 622 mellitus, Nature reviews Endocrinology, vol.7, pp.346-53, 2011. ,
Metabolism 624 disrupting chemicals and metabolic disorders, Reprod Toxicol, vol.68, pp.3-33, 2017. ,
Adiponectin: mechanistic insights and clinical implications, Diabetologia, vol.626, pp.2319-2345, 2012. ,
Fetal origins of adult disease: strength of effects and 628 biological basis, International journal of epidemiology, vol.31, pp.1235-1244, 2002. ,
Developmental origins of non-630 communicable disease: implications for research and public health, Environ Health, vol.11, p.42, 2012. ,
Bisphenol-A exposure in utero programs a 632 sexually dimorphic estrogenic state of hepatic metabolic gene expression, Reprod Toxicol, vol.633, pp.84-94, 2017. ,
Metabolism, variability and risk assessment, Toxicology, vol.268, pp.156-64, 2010. ,
, ST: standard chow diet; HF: high-fat high-706 sucrose diet; HF0: pollutant-free high-fat high-sucrose diet; HFp: high-fat high-sucrose diet 707 containing the mixture of pollutants. Sham: sham-operated mice
, 708 Ovx+E2: ovariectomized mice with E2 replacement
, Supplemental Figure 6: Comparison between treatment-matched HF0-fed and HFp-fed 762 mice. A. Body and adipose tissue weights
Blood glucose, plasma insulin and HOMA-IR ,
HF0: pollutant-free high-fat high-sucrose diet; HFp: high-fat 764 high-sucrose diet containing the mixture of pollutants. Sham: non-operated mice; Ovx: 765 ovariectomized mice ,